Portal de investigación
MArkers for Subclinical CArdiovascular Risk Assessment
Datos básicos
Objetivos del proyecto
Proposal full title: MArkers for Subclinical CArdiovascular Risk Assessment Proposal acronym: EU-MASCARA Type of funding scheme: Collaborative Project (CP) - Large-scale integrating project (IP) Work programme topics addressed: HEALTH 2011.2.4.2-2: Evaluation and validation studies of clinically useful biomarkers in prevention and management of cardiovascular diseases.
Documentos
- No hay documentos
Participantes
Grupos y Plataformas de I+D+i
Financiadores - Promotores
Resultados del Ensayo Clínico
Association of miR-126-3p, miR-1260b and miR-374a-5p with the incidence of heart failure in a population-based cohort: the Hortega Follow-Up Study
Article. 10.1016/j.ejim.2025.03.022; 10.1016/j.ejim.2025.03.022. 2025
High miR-126-3p levels associated with cardiovascular events in a general population
Martinez-Arroyo, Olga; (...); Cortes, Raquel
Article. 10.1016/j.ejim.2023.04.013. 2023
Inhibiting miR-200a-3p Increases Sirtuin 1 and Mitigates Kidney Injury in a Tubular Cell Model of Diabetes and Hypertension-Related Renal Damage
Article. 10.3390/biom15070995. 2025
Urinary- and Plasma-Derived Exosomes Reveal a Distinct MicroRNA Signature Associated With Albuminuria in Hypertension.
Perez-Hernandez, Javier; (...); Cortes, Raquel
Article. 10.1161/HYPERTENSIONAHA.120.16598. 2021
